CLOV | tickerfilter.com

Fundamental analysis

43%

Profitability 35%

Dept financing 32%

Liquidity 18%

Performance 60%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

3.24%

1 Month

20.54%

3 Months

-14.89%

6 Months

-30.75%

1 Year

-32.83%

2 Year

258.41%

Key data

Stock price

$2.39

P/E Ratio

N/A

DAY RANGE

$2.30 - $2.48

EPS

-$0.71

52 WEEK RANGE

$1.58 - $3.92

52 WEEK CHANGE

-$34.02

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

524.667 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

08-04-2025

BETA

2.14

PUBLIC FLOAT

AVERAGE 10 VOLUME

$4,352,085

AVERAGE 30 VOLUME

$5,054,042

Company detail

CEO: Vivek Garipalli
Region: US
Website: cloverhealth.com
Employees: 680
IPO year: 2020

Issue type: Common Stock
Market: XNAS
Industry: Insurance/Accident And Health Insurance
Sector: Finance, Insurance, And Real Estate

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company also focuses on non-insurance businesses.

CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE